Inventor · disambiguated record
Tetsuro Kikuchi
Also filed as: KIKUCHI TETSURO
25 granted patents·23 pending applications·495 citations·filing 1989–2024
97Inventor score
Top patents by PatentIndex Score
48 records- 0198US9522123B2Use of one or a combination of phyto-cannabinoids in the treatment of epilepsyGW PHARMA LTD·Filed 2014·Granted Dec 20, 2016·62 cites·13 claims
- 0296US9066920B2Use of one or a combination of phyto-cannabinoids in the treatment of epilepsyWHALLEY BEN·Filed 2010·Granted Jun 30, 2015·74 cites·13 claims
- 0396US9017737B2Use of cannabinoids in combination with an anti-psychotic medicamentKIKUCHI TETSURO·Filed 2008·Granted Apr 28, 2015·96 cites·21 claims
- 0495US8642600B2Method of treating autismJORDAN SHAUN·Filed 2011·Granted Feb 4, 2014·23 cites·2 claims
- 0594US7053092B25-HT1a receptor subtype agonistOTSUKA PHARMA CO LTD·Filed 2002·Granted May 30, 2006·59 cites·2 claims
- 0693US8426423B2Method of treating Attention Deficit Hyper-Activity DisorderJORDAN SHAUN·Filed 2007·Granted Apr 23, 2013·14 cites·2 claims
- 0790US8790719B2Phytocannabinoids in the treatment of cancerPAROLARO DANIELA·Filed 2011·Granted Jul 29, 2014·43 cites·1 claims
- 0889US9675654B2Phytocannabinoids in the treatment of cancerGW PHARMA LTD·Filed 2014·Granted Jun 13, 2017·17 cites·1 claims
- 0989US9089567B2Method of treating cognitive impairments and schizophreniasJORDAN SHAUN·Filed 2011·Granted Jul 28, 2015·7 cites·10 claims
- 1087US2025177385A1Combinations comprising brexpiprazole or a salt thereof and a second drug for use in the treatment of a cns disorderOTSUKA PHARMA CO LTD·Filed 2024·Application pending·0 cites
- 1185US8680105B2Method of treating down's syndromeJORDAN SHAUN·Filed 2011·Granted Mar 25, 2014·4 cites·2 claims
- 1284US9694009B2Carbostyril derivatives and serotonin reuptake inhibitors for treatment of mood disordersOTSUKA PHARMA CO LTD·Filed 2016·Granted Jul 4, 2017·3 cites·16 claims
- 1384US2024156811A1Combinations comprising brexpiprazole or a salt thereof and a second drug for use in the treatment of a cns disorderOTSUKA PHARMA CO LTD·Filed 2023·Application pending·0 cites
- 1482US2024024310A1Carbostyril derivatives and mood stabilizers for treating mood disordersOTSUKA PHARMA CO LTD·Filed 2023·Application pending·0 cites
- 1579US9387182B2Carbostyril derivatives and serotonin reuptake inhibitors for treatment of mood disordersOTSUKA PHARMA CO LTD·Filed 2014·Granted Jul 12, 2016·2 cites·32 claims
- 1679US4914094AMethod for treating hypoxiaOTSUKA PHARMA CO LTD·Filed 1989·Granted Apr 3, 1990·61 cites·15 claims
- 1778US8623874B2Method of treating neurodegenerative diseasesJORDAN SHAUN·Filed 2008·Granted Jan 7, 2014·1 cites·5 claims
- 1877US9387207B25-HT1A receptor subtype agonistOTSUKA PHARMA CO LTD·Filed 2015·Granted Jul 12, 2016·1 cites·2 claims
- 1977US9006248B25-HT1A receptor subtype agonistOTSUKA PHARMA CO LTD·Filed 2013·Granted Apr 14, 2015·1 cites·2 claims
- 2077US8604041B2Method of treating panic disorderJORDAN SHAUN·Filed 2011·Granted Dec 10, 2013·1 cites·2 claims
- 2176US8722680B2Method of treating neurodegenerative diseasesJORDAN SHAUN·Filed 2011·Granted May 13, 2014·1 cites·6 claims
- 2276US2020405712A1Method of treating bipolar i and ii disordersOTSUKA PHARMA CO LTD·Filed 2020·Application pending·0 cites
- 2376US2020246332A1Carbostyril derivatives and mood stabilizers for treating mood disordersOTSUKA PHARMA CO LTD·Filed 2019·Application pending·0 cites
- 2476US2020289501A1Carbostyril derivatives and serotonin reuptake inhibitors for treatment of mood disordersOTSUKA PHARMA CO LTD·Filed 2019·Application pending·0 cites
- 2574US2020093823A1Method of treating bipolar i and ii disordersOTSUKA PHARMA CO LTD·Filed 2019·Application pending·0 cites
- 2673US9125939B2Carbostyril derivatives and mood stabilizers for treating mood disordersKIKUCHI TETSURO·Filed 2004·Granted Sep 8, 2015·4 cites·10 claims
- 2773US2019151308A1Carbostyril derivatives and serotonin reuptake inhibitors for treatment of mood disordersOTSUKA PHARMA CO LTD·Filed 2019·Application pending·0 cites
- 2873US2022000861A1Combinations comprising brexpiprazole or a salt thereof and a second drug for use in the treatment of a cns disorderOTSUKA PHARMA CO LTD·Filed 2021·Application pending·0 cites
- 2972US2021308126A1Carbostyril derivatives and mood stabilizers for treating mood disordersOTSUKA PHARMA CO LTD·Filed 2020·Application pending·0 cites
- 3071US2018344731A1Method of treating bipolar i and ii disordersOTSUKA PHARMA CO LTD·Filed 2018·Application pending·0 cites
- 3169US8759350B2Carbostyril derivatives and serotonin reuptake inhibitors for treatment of mood disordersKIKUCHI TETSURO·Filed 2003·Granted Jun 24, 2014·4 cites·18 claims
- 3268US8030312B25-HT1A receptor subtype agonistOTSUKA PHARMA CO LTD·Filed 2004·Granted Oct 4, 2011·1 cites·6 claims
- 3367US2017224681A1Method of treating bipolar i and ii disordersOTSUKA PHARMA CO LTD·Filed 2017·Application pending·0 cites
- 3466US9895342B2Cannabinoids for use in the treatment of neuropathic painMAIONE SABATINO·Filed 2012·Granted Feb 20, 2018·2 cites·9 claims
- 3564US2018325894A1Combinations comprising brexpiprazole or a salt thereof and a second drug for use in the treatment of a cns disorderOTSUKA PHARMA CO LTD·Filed 2018·Application pending·0 cites
- 3663US2012238584A15-HT1A receptor subtype agonistJORDAN SHAUN·Filed 2012·Application pending·0 cites
- 3762US2018042923A1Combinations comprising brexpiprazole or a salt thereof and a second drug for use in the treatment of a cns disorderOTSUKA PHARMA CO LTD·Filed 2017·Application pending·0 cites
- 3861US2019247324A1One or a Combination of Phyto-Cannabinoids in the Treatment of EpilepsyGW PHARMA LTD·Filed 2018·Application pending·0 cites
- 3960US2017258788A1Carbostyril derivatives and serotonin reuptake inhibitors for treatment of mood disordersOTSUKA PHARMA CO LTD·Filed 2017·Application pending·0 cites
- 4059US2010273810A1Method of treating cognitive impairments and schizophreniasOTSUKA PHARMA CO LTD·Filed 2010·Application pending·0 cites
- 4159US2017100395A1Combinations comprising brexpiprazole or a salt thereof and a second drug for use in the treatment of a cns disorderOTSUKA PHARMA CO LTD·Filed 2016·Application pending·0 cites
- 4256US2017273913A1Use of one or a combination of phyto-cannabinoids in the treatment of epilepsyGW PHARMA LTD·Filed 2016·Application pending·0 cites
- 4356US2014120185A1Combinations comprising brexpiprazole or a salt thereof and a second drug for use in the treatment of a cns disorderHIROSE TSUYOSHI·Filed 2012·Application pending·0 cites
- 4454US2016030423A1Carbostyril derivatives and mood stabilizers for treating mood disordersOTSUKA PHARMA CO LTD·Filed 2015·Application pending·0 cites
- 4549US2018042975A1Phytocannabinoids in the treatment of cancerGW PHARMA LTD·Filed 2017·Application pending·0 cites
- 4645US5556857ADisturbance-of-consciousness improving agentOTSUKA PHARMA CO LTD·Filed 1993·Granted Sep 17, 1996·10 cites·19 claims
- 4740US5656633ACarbostyril derivatives and pharmaceutical compositions containing the same for use as a disturbance-of-consciousness improving agent, central nervous system stimulant or sigma receptor agonistOTSUKA PHARMA CO LTD·Filed 1995·Granted Aug 12, 1997·3 cites·13 claims
- 4833US5506230AFatty emulsionOTSUKA PHARMA CO LTD·Filed 1993·Granted Apr 9, 1996·1 cites·20 claims
Join the waitlist — get patent alerts
Get an alert when Tetsuro Kikuchi files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →